drugset / Trial / NCT06558253

The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT

NCT06558253 ↗

Phase 1 Recruiting 12 enrolled Anhui Provincial Hospital
NaSequentialOpen-labelTreatment

Summary

To assess the safety and efficacy of coenzyme I for injection in promoting hematopoietic recovery after single-unit unrelated cord blood transplantation in hematological malignancies.

Timeline

Start
2024-11-29
Primary completion
2026-04-01
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme I for Injection Unknown 10 mg Intravenous
Subject Coenzyme I for Injection Unknown 20 mg Intravenous
Subject Coenzyme I for Injection Unknown 50 mg Intravenous